Browsing School of Health Sciences & School of Nursing by Author "Magambo, Japheth K"
Now showing items 1-4 of 4
-
Factors associated with the motivation of community drug distributors in the Lymphatic Filariasis Elimination Programme in Kenya
Njomo, Doris W; Amuyunzu-Nyamongo, Mary; Magambo, Japheth K; Ngure, Peter K; Njenga, Sammy M (Cogent OA, 2012)Annual mass drug administration (MDA) is the main strategy for elimination of lymphatic flariasis (LF), globally. In Kenya, community drug distributors (CDDs) are used to deliver drugs to household members. To determine ... -
Gross and histopathological findings in Cercopithecus aethiops with experimental Cyclospora infection in Kenya
Nguhiu, Purity N; Wamae, Claire N; Magambo, Japheth K; Mbuthia, Paul G; Cha, Daniel C; Yole, Dorcas S (Pathology and Laboratory Medicine International, 2012)In 2009, experimental Cyclospora infections were established in two juvenile female and two adult male Cercopithecus aethiops (African green monkeys) at Nairobi’s Institute of Primate Research (IPR). The ... -
The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya
Njomo, Doris W; Amuyunzu-Nyamongo, Mary; Magambo, Japheth K; Njenga, Sammy M (Public Library of Science, 2012)The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual mass drug administration (MDA) for 4 to 6 rounds. At least 65% of the population at risk should be treated in each round for LF elimination ... -
Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results
Njomo, Doris W; M Amuyunzu-Nyamongo; Mukoko, Dunstan A; Magambo, Japheth K; Njenga, Sammy M (Medknow Publications, 2012)Annual Mass Drug Administration (MDA) to at least 65 – 80% of the population at risk is necessary for Lymphatic Filariasis (LF) elimination. In Kenya, MDA based on diethylcarbamazine and albendazole, using the community-directed ...